CELU·Nasdaq·US
Celularity
Celularity is a US-based regenerative and cellular medicine company focused on placental-derived therapeutics and biomaterial products. It generates revenue from cell-therapy-related commercial operations, biomaterials, biobanking services, and related licensing and royalties.
Recent Activity
Updated Oct 24, 2026
–Celularity regained compliance with Nasdaq's periodic reporting requirement after filing its second-quarter 2026 Form 10-Q, and Nasdaq closed the reporting deficiency.
Past updates are part of the Pro plan.
Thematic Position
Relationship Groups
Relationship details are part of the Pro plan.